SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation
Journal of Virology · 2026
DOI: 10.1128/jvi.00186-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Lujie Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Department of Biochemistry, the…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, PTEN Phosphohydrolase, Proteasome Endopeptidase Complex, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund for Distinguished Young Scholars, Major project of Guangzhou national laboratory, National Natural Science Foundation of China.
Abstract (Originalsprache)
Human coronaviruses (HCoVs) are a group of RNA viruses characterized by high genetic variability and cross-species transmission potential. They can cause a wide spectrum of respiratory illnesses, ranging from mild upper respiratory tract infections to severe pneumonia, and acute respiratory distress syndrome. PTEN, a well-known tumor suppressor, not only plays a crucial role in tumorigenesis but also enhances antiviral immunity by regulating IRF3 phosphorylation and promoting type I interferon production. In this study, we observed that PTEN significantly inhibited the replication of various HCoVs, including SARS-CoV-2, HCoV-229E, and HCoV-OC43. However, SARS-CoV-2 infection antagonizes the antiviral function of PTEN. Mechanistically, PTEN undergoes ubiquitination at lysine 6, followed by proteasomal degradation after SARS-CoV-2 infection. Through screening, it was found that STUB1 is the key E3 ligase responsible for PTEN degradation under SARS-CoV-2 infection. Furthermore, screening of SARS-CoV-2-encoded proteins revealed that ORF3a promotes STUB1-mediated PTEN ubiquitination and degradation at K6. Previous studies have shown that Oroxin B can exert the effect of a PTEN agonist by upregulating the expression of PTEN. In this study, we demonstrated that Oroxin B significantly enhances antiviral responses in mice. In conclusion, this study reveals the molecular mechanism by which SARS-CoV-2 evades PTEN-mediated antiviral effects, providing new insights for the development of PTEN-targeted antiviral strategies. IMPORTANCE Human coronaviruses continue to threaten global health, yet how these viruses evade our natural antiviral defenses remains poorly understood. This study reveals that PTEN, a well-known tumor suppressor, also acts as a powerful antiviral molecule capable of limiting multiple human coronaviruses, including SARS-CoV-2. We further show that SARS-CoV-2 dismantles this protection by triggering PTEN degradation through the host enzyme STUB1 and the viral protein ORF3a. This discovery uncovers a previously unknown strategy used by coronaviruses to weaken innate immunity. Importantly, we identify Oroxin B as a promising compound that enhances antiviral responses in vivo . Together, our findings provide new insight into how coronaviruses disarm host defenses and highlight PTEN as a potential target for broad-spectrum antiviral therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Department of Biochemistry, the Second Affiliated Hospital, School of Medicine, Southern University o…
- Guangdong Key Laboratory for Anti-Infection Drug Quality Evaluation, Shenzhen, Guangdong, China.
- Shenzhen Research Center for Communicable Disease Diagnosis, Treatment of Chinese Academy of Medical Science, Shenzhen, Guangdong, China.
ORCID-Profile: Lujie Fan, Yuzheng Zhou
Förderung
- National Science Fund for Distinguished Young Scholars
- Major project of Guangzhou national laboratory
- National Natural Science Foundation of China
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research Foundation
- Postdoctoral Research Foundation of China
Zitieren
APA
Fan, L., Gao, X., Feng, W., Huang, Q., Wei, X., Yang, C., Wu, Y., Shen, X., Zhao, J., Zhou, Y., & Zhang, Z. (2026). SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation. Journal of Virology. https://doi.org/10.1128/jvi.00186-26
Vancouver
Fan L, Gao X, Feng W, Huang Q, Wei X, Yang C, et al. SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation. Journal of Virology. 2026. doi:10.1128/jvi.00186-26
BibTeX
@article{Fan2026,
author = {Fan, Lujie and Gao, Xiang and Feng, Wei and Huang, Qiang and Wei, Xiafei and Yang, Chuwei and Wu, Yezi and Shen, Xiaotong and Zhao, Juanjuan and Zhou, Yuzheng and Zhang, Zheng},
title = {SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation},
journal = {Journal of Virology},
year = {2026},
doi = {10.1128/jvi.00186-26}
}
EUVIMED